TRAF2 and hepatocellular carcinoma: For example, SPHK1, a regulator of sphingolipid metabolism, by binding TRAF2 (TNF receptor-associated factor 2) and Beclin-1, activates autophagy and thereby induces the degradation of E-cadherin, EMT, and the metastatic progression of hepatocellular carcinoma [145].